Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
18 April 2017 |
Main ID: |
ChiCTR-OPC-15006125 |
Date of registration:
|
2015-03-19 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Comparison of the nephrotoxicity of vancomycin monotherapy and combined with piperacillin tazobactam in pediatric inpatients
|
Scientific title:
|
Comparison of efficacy and adverse reactions of vancomycin monotherapy and combined with piperacillin tazobactam |
Date of first enrolment:
|
2015-03-23 |
Target sample size:
|
1:125;2:125; |
Recruitment status: |
Pending |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=10614 |
Study type:
|
Observational study |
Study design:
|
Cohort study
|
Phase:
|
Post-market
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Li Zhiping
|
Address:
|
399 Wanyuan Road, Minhang, Shanghai
201102
|
Telephone:
|
+86 021 64932030 |
Email:
|
zhipinglifudan@yeah.net |
Affiliation:
|
|
|
Name:
|
Li Jing
|
Address:
|
399 Wanyuan Road, Minhang, Shanghai
201102
|
Telephone:
|
+86 15201928260 |
Email:
|
lijing2007good@163.com |
Affiliation:
|
Children's Hospital of Fudan University |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: The inpatients aged 0-10,of which the treatment is vancomycin monotherapy or combined with piperacillin tazobactam
Exclusion criteria: Serious liver and kidney dysfunction
Age minimum:
0
Age maximum:
10
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Severe infections
|
Intervention(s)
|
1:vancomycin monothepy;2:piperacillin tazobactam combination of vancomycin;
|
Primary Outcome(s)
|
nephrotoxicity;
|
Source(s) of Monetary Support
|
National Natural Science Foundation of China
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|